发明名称 PYRAZOLOPYRIMIDINONE cGMPPDE5 INHIBITOR FOR THERAPY OF SEXUAL FUNCTIONAL DISORDER
摘要 PROBLEM TO BE SOLVED: To obtain a new pyrazolopyrimidinone cGMPPDE5 inhibitor useful for the therapy of disorders concerning male erection function or the like as an inhibitor against a guanosine 3',5'-cyclic monophosphate phosphodiesterase. SOLUTION: This new compound is expressed by formula I or II (wherein, A is CH or N; R1 and R2 are each H, an aryl or the like; R3 is H or a lower alkyl; R4 is SO2NR12R13; R12 is R13 combine each with N and together form a 4-12 membered heterocyclic group having nitrogen atom), and is, e.g. 3- benzyl-6-[2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl]-1-n-propy l-1,5-dihydro-4 H-pyrazolo[3,4-d]pyrimidin-4-one. The compound of formula I is obtained by the cyclization of a new intermediate compound of formula IV obtained from a compound of formula III as a starting substance.
申请公布号 JP2000128884(A) 申请公布日期 2000.05.09
申请号 JP19990302064 申请日期 1999.10.25
申请人 PFIZER INC 发明人 MARK EDWARD BANNEIJI;MATHIAS JOHN PAUL;STEVEN DEREK ALBERT STREET;ANTHONY WOOD
分类号 A61K31/519;A61K31/5377;A61P1/00;A61P9/00;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/00;A61P13/08;A61P13/10;A61P15/10;A61P17/00;A61P17/06;A61P17/14;A61P25/00;A61P25/28;A61P27/06;A61P35/04;A61P43/00;C07D487/04;(IPC1-7):C07D487/04 主分类号 A61K31/519
代理机构 代理人
主权项
地址